ZBH - Zimmer Biomet Holdings, Inc.

NYSE - NYSE Delayed Price. Currency in USD
123.65
+1.16 (+0.95%)
At close: 4:01PM EST
Stock chart is not supported by your current browser
Previous Close122.49
Open123.80
Bid0.00 x 1200
Ask0.00 x 800
Day's Range122.42 - 124.23
52 Week Range96.99 - 134.55
Volume1,212,543
Avg. Volume1,411,765
Market Cap25.222B
Beta (3Y Monthly)1.38
PE Ratio (TTM)N/A
EPS (TTM)-1.86
Earnings DateApr 24, 2019 - Apr 29, 2019
Forward Dividend & Yield0.96 (0.78%)
Ex-Dividend Date2018-12-27
1y Target Est130.21
Trade prices are not sourced from all markets
  • GuruFocus.com2 days ago

    Weekly Top Insider Buys Highlight for the Week of Feb. 15

    The largest Insider Buys this week were for Celgene Corp. (CELG), Yum Brands Inc. (YUM), Omega Healthcare Investors Inc. (OHI) and Zimmer Biomet Holdings Inc. (ZBH). Director Ernest Mario bought 2,000 shares of CELG stock on Feb. 12 at the average price of $89.99. Warning! GuruFocus has detected 3 Warning Signs with CELG.

  • GuruFocus.com6 days ago

    Jeff Auxier Comments on Zimmer Biomet Holdings

    Guru stock highlight

  • GuruFocus.com7 days ago

    Jeff Auxier's Winter 2018 Market Commentary

    Discussion of markets and holdings

  • GuruFocus.com7 days ago

    Weekly CEO Buys Highlight

    Insiders invest in New Fortress Energy, WisdomTree Investments, Zimmer Biomet Holdings, FS KKR Capital and Bain Capital Specialty Finance

  • Smith & Nephew Drops on Report of Deal Talks With NuVasive
    Bloomberg7 days ago

    Smith & Nephew Drops on Report of Deal Talks With NuVasive

    NuVasive share rose 11 percent to $54.85 at 9:57 a.m. in New York, after a report Friday in the Financial Times on the possible interest from the U.K. company. Smith & Nephew recently signaled its readiness to pursue a bigger deal, with Chief Executive Officer Namal Nawana saying last week the company wants to play in more areas of medical devices. The market questioned the rationale of buying NuVasive, however.

  • GuruFocus.com10 days ago

    Weekly Top Insider Buys Highlight for the Week of Feb. 8

    The largest Insider Buys this week were for AT&T Inc. (NYSE:T), Biogen Inc. (BIIB), Abbott Laboratories (ABT) and Zimmer Biomet Holdings Inc. (ZBH). Warning! GuruFocus has detected 5 Warning Signs with T. Click here to check it out. AT&T Inc. an American multinational telecommunications conglomerate that is the second largest provider of mobile telephone services and the largest provider of fixed telephone services in the U.S. It also provides broadband subscription television services through DirecTV.

  • Reuters10 days ago

    Smith & Nephew in talks to buy NuVasive for over $3 billion - FT

    When contacted by Reuters, Smith & Nephew and NuVasive said they do not comment on market speculation. The exact terms of any talks could not be learned, and the discussions may still fall apart, the FT reported. The acquisition would mark the first major move by Smith & Nephew Chief Executive Namal Nawana.

  • GuruFocus.com10 days ago

    Zimmer Biomet Holdings Inc (ZBH) President and CEO Bryan C Hanson Bought $249,942 of Shares

    President and CEO of Zimmer Biomet Holdings Inc (NYSE:ZBH) Bryan C Hanson bought 2,100 shares of ZBH on 02/07/2019 at an average price of $119.02 a share.

  • Markit10 days ago

    See what the IHS Markit Score report has to say about Zimmer Biomet Holdings Inc.

    Zimmer Biomet Holdings Inc NYSE:ZBHView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for ZBH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ZBH. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding ZBH totaled $15.64 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • GlobeNewswire12 days ago

    Detailed Research: Economic Perspectives on Edwards Lifesciences, Zimmer Biomet, American Outdoor Brands, Radius Health, Kaman, and FARO Technologies — What Drives Growth in Today's Competitive Landscape

    Detailed Research: Economic Perspectives on Edwards Lifesciences, Zimmer Biomet, American Outdoor Br, Feb. 06, 2019 -- In new independent research reports released early this.

  • Thomson Reuters StreetEvents13 days ago

    Edited Transcript of ZBH earnings conference call or presentation 1-Feb-19 1:30pm GMT

    Q4 2018 Zimmer Biomet Holdings Inc Earnings Call

  • Zimmer Biomet (ZBH) Jumps: Stock Rises 6.4%
    Zacks14 days ago

    Zimmer Biomet (ZBH) Jumps: Stock Rises 6.4%

    Zimmer Biomet (ZBH) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

  • Zimmer Biomet Holdings Inc (ZBH) Q4 2018 Earnings Conference Call Transcript
    Motley Fool17 days ago

    Zimmer Biomet Holdings Inc (ZBH) Q4 2018 Earnings Conference Call Transcript

    ZBH earnings call for the period ending December 31, 2018.

  • Zimmer Biomet (ZBH) Q4 Earnings Meet Estimates, Revenues Top
    Zacks17 days ago

    Zimmer Biomet (ZBH) Q4 Earnings Meet Estimates, Revenues Top

    Zimmer Biomet (ZBH) sees strength in the Asia Pacific and EMEA regions as well as in the Spine & CMF business in Q4.

  • Zimmer Biomet (ZBH) Meets Q4 Earnings Estimates
    Zacks17 days ago

    Zimmer Biomet (ZBH) Meets Q4 Earnings Estimates

    Zimmer (ZBH) delivered earnings and revenue surprises of 0.00% and 0.54%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press17 days ago

    Zimmer: 4Q Earnings Snapshot

    On a per-share basis, the Warsaw, Indiana-based company said it had a loss of $4.42. Earnings, adjusted for asset impairment costs and non-recurring costs, were $2.18 per share. The results met Wall Street ...

  • PR Newswire17 days ago

    Zimmer Biomet Announces Fourth Quarter and Full-Year 2018 Financial Results

    - Net sales of $2.071 billion for the fourth quarter represent an increase of 0.1% over the prior year period, and an increase of 1.6% on a constant currency basis - Diluted loss per share for the fourth ...

  • ZBH & IDXX Q4 Earnings on Feb 1: Here are the Key Predictions
    Zacks18 days ago

    ZBH & IDXX Q4 Earnings on Feb 1: Here are the Key Predictions

    The global medical device space is passing through a rewarding phase for a considerable period of time in terms of research and development (R&D) plus regulatory progress.

  • PR Newswire20 days ago

    Zimmer Biomet Holdings to Present at 8th Annual SVB Leerink Global Healthcare Conference

    WARSAW, Ind. , Jan. 29, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the 8 th Annual SVB Leerink Global Healthcare ...

  • Medical Products Industry Outlook: Plenty of Upside Left
    Zacks20 days ago

    Medical Products Industry Outlook: Plenty of Upside Left

    Medical Products Industry Outlook: Plenty of Upside Left

  • Can Zimmer Biomet (ZBH) Grow on Hip Business in Q4 Earnings?
    Zacks21 days ago

    Can Zimmer Biomet (ZBH) Grow on Hip Business in Q4 Earnings?

    Within Hip business, we expect Zimmer Biomet (ZBH) to experience a strong uptick in the Asia-Pacific region.

  • Zimmer Biomet (ZBH) Reports Next Week: Wall Street Expects Earnings Growth
    Zacks24 days ago

    Zimmer Biomet (ZBH) Reports Next Week: Wall Street Expects Earnings Growth

    Zimmer (ZBH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • PR Newswire24 days ago

    Zimmer Biomet Receives FDA Clearance for ROSA® Knee System for Robotically-Assisted Surgeries

    WARSAW, Ind., Jan. 25, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration 510(k) clearance of the ROSA® Knee System for robotically-assisted total knee replacement surgeries. ROSA Knee features 3D pre-operative planning tools and real-time, intraoperative data on soft-tissue and bone anatomy designed to improve bone cut accuracy and range of motion gap analysis to potentially improve flexion and restoration of natural joint movement. "Complementing the skill and expertise of the surgeon with ROSA Knee's robotically-assisted technologies can improve accuracy, precision and consistency, which can improve patient satisfaction, clinical outcomes and efficiency," said Christopher J. Cannova, M.D., Washington Joint Institute at OrthoBethesda.

  • Becton, Dickinson Expected to Continue to Reward Shareholders
    GuruFocus.com25 days ago

    Becton, Dickinson Expected to Continue to Reward Shareholders

    Medical device companies need to focus on value and disease prevention or their products risk becoming commodities, according to a recent report by consulting firm KPMG. Warning! GuruFocus has detected 3 Warning Signs with ZBH.